At the 2024 UCSF-UCLA PSMA Conference, Thomas Hope explores the impact of PSMA PET imaging on prostate cancer care, emphasizing the ProPSMA trial's comparison of PSMA PET to conventional imaging and the PreRP trial's pursuit of FDA approval, highlighting their roles in enhancing diagnosis and treatment.
|